| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Marizyme Inc (OTCQB: MRZM)
MRZM Technical Analysis
5
| As on 11th Mar 2025 MRZM STOCK Price closed @ 0.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.13 & Strong Sell for SHORT-TERM with Stoploss of 0.12 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRZMSTOCK Price
| Open | 0.00 | Change | Price | % |
| High | 0.00 | 1 Day | -0.02 | -100.00 |
| Low | 0.00 | 1 Week | -0.04 | -100.00 |
| Close | 0.00 | 1 Month | -0.04 | -100.00 |
| Volume | 523 | 1 Year | -0.11 | -100.00 |
| 52 Week High 0.33 | 52 Week Low 0.02 | ||||
OTCQB USA Most Active Stocks
| FNMA | 4.98 | 9.69% |
| BMIX | 0.01 | % |
| GCAN | 0.00 | % |
| BTCWF | 0.10 | 150.00% |
| EMED | 0.00 | % |
| FMCC | 4.94 | 12.53% |
| INVU | 0.02 | 100.00% |
| KGKG | 0.00 | % |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| MRZM Daily Charts |
MRZM Intraday Charts |
Whats New @ Bazaartrend |
MRZM Free Analysis |
|
|
MRZM Important Levels Intraday
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
| RESISTANCE | 0.00 |
MRZM Forecast March 2025
| 4th UP Forecast | 0.48 |
| 3rd UP Forecast | 0.33 |
| 2nd UP Forecast | 0.23 |
| 1st UP Forecast | 0.14 |
| 1st DOWN Forecast | -0.14 |
| 2nd DOWN Forecast | -0.23 |
| 3rd DOWN Forecast | -0.33 |
| 4th DOWN Forecast | -0.48 |
MRZM Weekly Forecast
| 4th UP Forecast | 0.19 |
| 3rd UP Forecast | 0.13 |
| 2nd UP Forecast | 0.09 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | -0.05 |
| 2nd DOWN Forecast | -0.09 |
| 3rd DOWN Forecast | -0.13 |
| 4th DOWN Forecast | -0.19 |
MRZM Forecast2025
| 4th UP Forecast | 0.79 |
| 3rd UP Forecast | 0.54 |
| 2nd UP Forecast | 0.38 |
| 1st UP Forecast | 0.22 |
| 1st DOWN Forecast | -0.22 |
| 2nd DOWN Forecast | -0.38 |
| 3rd DOWN Forecast | -0.54 |
| 4th DOWN Forecast | -0.79 |
Marizyme Inc ( OTCQB USA Symbol : MRZM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRZM Business Profile
Marizyme, Inc., a development stage company, focuses on life science technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform, which includes MB101 for complex wounds and burns; MB102 for acute ischemic stroke; MB104 for deep vein thrombosis; and MB105 for dissolving plaque and biofilms on teeth. In addition, it focuses on developing products to mitigate the effects of ischemia reperfusion injury in other grafting and transplantation surgeries, and other indications. The company was formerly known as GBS Enterprises Incorporated. Marizyme, Inc. was incorporated in 2007 and is based in Jupiter, Florida. Address: 555 Heritage Drive, Jupiter, FL, United States, 33458
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service